Received Feb 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z004811 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z011894 | — |
No additional AE; The nurse is reporting that a patient received improperly stored vaccine. No additional AE/No PQC reported. Names of vaccines involved (including lot/exp) MMR II (Z004811 2/20/2027) Temperature: 50.4F Time frame: 1-hour Previous temperature excur; This spontaneous report was received from a Nurse and refers to a(n) 1-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 02-Feb-2026, the patient was vaccinated with improperly stored dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), lot #Z004811, expiration date: 20-Feb-2027 (formulation, exact dose, route of administration and anatomical location were not provided) for prophylaxis. On the same date, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), lot #Z011894, expiration date: 17-Jul-2027 (formulation, exact dose, route of administration and anatomical location were not provided) for prophylaxis. These vaccines were reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT), (lot # and expiration date were not reported). On the same date, the patient was vaccinated with Havrix (Hepatitis a vaccine inact) (formulation, lot #, expiration date, exact dose, route of administration and anatomical location were not provided) for prophylaxis. Administered dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) vaccine was exposed to the temperature excursion of 50.4 degrees Fahrenheit (F) for 1 hour (product storage error). No previous temperature excursion. No additional adverse event (no adverse event). On 02-Feb-2026, the patient experienced The nurse is reporting that a patient received improperly stored vaccine. No additional AE/No PQC reported. Names of vaccines involved (including lot/exp) MMR II (z004811 2/20/2027) Temperature: 50.4F Time frame: 1 hour Previous temperature excur. On an unknown date, the patient experienced No additional AE. At the reporting time, the outcome of No additional AE and The nurse is reporting that a patient received improperly stored vaccine. No additional AE/No PQC reported. Names of vaccines involved (including lot/exp) MMR II (z004811 2/20/2027) Temperature: 50.4F Time frame: 1-hour Previous temperature excur was unknown. The action taken with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live. nsterile diluent and Varicella Virus Vaccine Live (Oka-Merck) was reported as not applicable. The action taken with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live lyophilisate and solvent for solution for injection. nsterile diluent Solution for injection. nVaricella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection and Havrix (Hepatitis a vaccine inact) was reported as not applicable.
sterile diluent